Cassava Sciences, Inc.
SAVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,342 | -$97,217 | -$76,246 | -$32,385 |
| Dep. & Amort. | $1,132 | $1,530 | $1,301 | $534 |
| Deferred Tax | $0 | $0 | -$8,117 | $3,388 |
| Stock-Based Comp. | $16,291 | $0 | $2,066 | $1,759 |
| Change in WC | -$1,827 | $9,076 | -$4,635 | -$104 |
| Other Non-Cash | -$108,183 | $4,586 | $8,117 | -$3,388 |
| Operating Cash Flow | -$116,929 | -$82,025 | -$77,514 | -$30,196 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$103 | -$414 | -$2,712 | -$22,214 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$103 | -$414 | -$2,712 | -$22,214 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $124,470 | $2,560 | $47,329 | $189,825 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $475 | $2,516 |
| Financing Cash Flow | $124,470 | $2,560 | $47,804 | $192,341 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,438 | -$79,879 | -$32,422 | $139,931 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $121,136 | $201,015 | $233,437 | $93,506 |
| End Cash | $128,574 | $121,136 | $201,015 | $233,437 |
| Free Cash Flow | -$117,032 | -$82,439 | -$80,226 | -$52,410 |